Assignee
MEDYTOX INC
KR·8 granted patents·15 pending applications·9 citations·filing 2014–2024
Top patents by PatentIndex Score
23 records- 0181US11331598B2Method of isolating botulinum toxin from botulinum toxin-containing solutionMEDYTOX INC·Filed 2017·Granted May 17, 2022·4 cites·9 claims
- 0275US10105387B2Temperature sensitive adhesion prevention composition and use thereofMEDYTOX INC·Filed 2014·Granted Oct 23, 2018·4 cites·14 claims
- 0373US10729700B2Methods and compositions of bile acids and salts for reduction of fatMEDYTOX INC·Filed 2015·Granted Aug 4, 2020·1 cites·12 claims
- 0469US2025099560A1Composition for Stabilizing Botulinum Neurotoxin, Botulinum Neurotoxin Formulation Containing Same, and Polypeptides for Use ThereinMEDYTOX INC·Filed 2024·Application pending·0 cites
- 0564US11517576B2Methods and compositions of bile acids and salts for reduction of fatMEDYTOX INC·Filed 2020·Granted Dec 6, 2022·0 cites·13 claims
- 0658US2025018016A1Botulinum neurotoxin compositionMEDYTOX INC·Filed 2022·Application pending·0 cites
- 0757US2024216576A1Hyaluronic acid cross-linked product, and filler composition comprising sameMEDYTOX INC·Filed 2022·Application pending·0 cites
- 0857US2024034800A1Anti-hvem antibody, and composition and method associated with sameMEDYTOX INC·Filed 2021·Application pending·0 cites
- 0957US2024254196A1Heterodimeric fc fusion protein, and composition, use, and method related to sameMEDYTOX INC·Filed 2021·Application pending·0 cites
- 1056US2023256064A1Cancer therapeutic agentMEDYTOX INC·Filed 2021·Application pending·0 cites
- 1155US11161872B2Methods for preparing bile acidsMEDYTOX INC·Filed 2018·Granted Nov 2, 2021·0 cites·15 claims
- 1255US2025325468A1Peptide inhibiting formation of snare complex and use thereofMEDYTOX INC·Filed 2021·Application pending·0 cites
- 1354US2022009957A1Methods for Preparing Bile AcidsMEDYTOX INC·Filed 2021·Application pending·0 cites
- 1452US11801276B2Microorganism having ability to degrade ethanol and acetaldehyde, and composition and kit each including the sameMEDYTOX INC·Filed 2018·Granted Oct 31, 2023·0 cites·10 claims
- 1552US2024301382A1Recombinant botulinum toxin type a light chain, recombinant botulinum toxin, and composition, use, and method thereofMEDYTOX INC·Filed 2022·Application pending·0 cites
- 1650US11198859B2Recombinant polynucleotide coding for polypeptide comprising reporter moiety, substrate moiety and destabilizing moiety, host cell comprising same and use of sameMEDYTOX INC·Filed 2017·Granted Dec 14, 2021·0 cites·15 claims
- 1750US2023165946A1Botulinum toxin pre-filled injectable formulation that facilitates discharge rate control and is stableMEDYTOX INC·Filed 2021·Application pending·0 cites
- 1850US2023141868A1Microorganism for improving liver function or inhibiting fat accumulation, and uses of sameMEDYTOX INC·Filed 2020·Application pending·0 cites
- 1949US2024294893A1Recombinant botulinum toxin type a light chain, recombinant botulinum toxin, and composition, use, and method thereofMEDYTOX INC·Filed 2022·Application pending·0 cites
- 2048US2023126726A1Crosslinked hyaluronic acid and use thereofMEDYTOX INC·Filed 2021·Application pending·0 cites
- 2144US12419836B2Extracellular vesicles derived from recombinant microorganism including polynucleotide encoding target protein and use thereofMEDYTOX INC·Filed 2019·Granted Sep 23, 2025·0 cites·15 claims
- 2244US2024067711A1Anti-vegf hexameric antibody and composition comprising sameMEDYTOX INC·Filed 2021·Application pending·0 cites
- 2343US2022111009A1Exogenous protein-expressing microorganism and use thereofMEDYTOX INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MEDYTOX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →